Product Information

ZAFIRLUKAST 10 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.5416 per EA under NDC 64380018701. Its NADAC has been published 220 times since Aug 31, 2022.

FDA first approved this application on Sep 26, 1996. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ZAFIRLUKAST 10 MG TABLET

zafirlukast
$0.5416per EA

Strength

10 mg/1

NDC

64380018701

Classification

Generic

Dosage Form

TABLET, COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

ZAFIRLUKAST

Approval Type

New Drug (NDA)

FDA Application

NDA020547

FDA Approved

9/26/1996

TE Code

AB

On Market Since

9/15/2022

Pharmacological Classes

Cytochrome P450 2C9 Inhibitors
Leukotriene Receptor Antagonist
Leukotriene Receptor Antagonists

Price Statistics

The NADAC for ZAFIRLUKAST 10 MG TABLET has been published 220 times since Aug 31, 2022, and over the history we have for it it has declined 47.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5416 per EA
All-time high$1.0259 (Nov 16, 2022)
All-time low$0.4056 (Feb 19, 2025)
52-week high$0.5416
52-week low$0.5023
Median price$0.6336
Average price$0.6671
Largest weekly change+24.7% (Dec 20, 2023)
Weeks tracked220
Tracking sinceAug 31, 2022

Price History

1W

0.0%

1M

+4.8%

3M

+0.6%

6M

+7.8%

1Y

-6.9%

3Y

-27.1%

5Y

N/A

All

-47.2%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the zafirlukast market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ZAFIRLUKAST 10 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ZAFIRLUKAST 10 MG TABLET, manufactured by Strides Pharma Inc., is $0.5416 per EA (NDC 64380018701), effective Nov 11, 2026.

How has the price of ZAFIRLUKAST 10 MG TABLET changed over time?

Over the history we have for it, the NADAC for ZAFIRLUKAST 10 MG TABLET has declined 47.2%. It has been tracked across 220 weekly CMS publications since Aug 31, 2022.

What are the highest and lowest recorded NADAC prices for ZAFIRLUKAST 10 MG TABLET?

Since Aug 31, 2022, the NADAC for ZAFIRLUKAST 10 MG TABLET has ranged from a low of $0.4056 (Feb 19, 2025) to a high of $1.0259 (Nov 16, 2022), with a median of $0.6336 per EA.

Are there cheaper alternatives to ZAFIRLUKAST 10 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of ZAFIRLUKAST 10 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ZAFIRLUKAST 10 MG TABLET?

ZAFIRLUKAST 10 MG TABLET (NDC 64380018701) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.